ConductScience.org, home

Paper37542151

CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease.

Narváez-Pérez LF and 5 others. Gene Ther, 2024. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease. Papers, record 37542151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37542151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease.
PubMed
Journal
Gene Ther
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
2.39, provisional
iCite
Revised in PubMed
2024-06-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Narváez-Pérez LFLuis Fernandohttps://orcid.org/0000-0002-4234-2549
2Paz-Bermúdez FFrancisco
3Avalos-Fuentes JAJosé Arturo
4Campos-Romo AAurelio
5Florán-Garduño BBenjamín
6Segovia JJoséhttps://orcid.org/0000-0001-8215-4772

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Parkinson DiseaseMajor topic
Neurodegenerative DiseasesMajor topic
Rats
Animals
RNA, Guide, CRISPR-Cas Systems
Oxidopamine
Rats, Sprague-Dawley
Clustered Regularly Interspaced Short Palindromic Repeats
Dopamine
Corpus Striatum
Tyrosine 3-Monooxygenase
Substantia Nigra

Source PubMed

Download CSV of topics

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129710735Gene Therapy for Parkinson's Disease, An Update.J Parkinsons Dis2018https://conductscience.org/library/papers/29710735PubMed
223287972Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.J Neurol2013https://conductscience.org/library/papers/23287972PubMed
310877925Real-time dynamics of dopamine released from neuronal transplants in experimental Parkinson's disease.Exp Neurol2000https://conductscience.org/library/papers/10877925PubMed
423238327D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat.Neuropharmacology2013https://conductscience.org/library/papers/23238327PubMed
58469306Dopamine-rich grafts in the neostriatum and/or nucleus accumbens: effects on drug-induced behaviours and skilled paw-reaching.Neuroscience1993https://conductscience.org/library/papers/8469306PubMed
68281440Decarboxylation of L-dopa by cultured mouse astrocytes.Brain Res1993https://conductscience.org/library/papers/8281440PubMed
726090233Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B.Neural Plast2015https://conductscience.org/library/papers/26090233PubMed
84332693Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.Acta Physiol Scand Suppl1971https://conductscience.org/library/papers/4332693PubMed
929257290Time-course behavioral features are correlated with Parkinson's disease‑associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model.Mol Med Rep2018https://conductscience.org/library/papers/29257290PubMed
1031963575Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease.J Clin Med2020https://conductscience.org/library/papers/31963575PubMed
119808338Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease.J Neurol1998https://conductscience.org/library/papers/9808338PubMed
1232848096CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice.Sci Transl Med2020https://conductscience.org/library/papers/32848096PubMed
1330474172Immune system responses in Parkinson's disease: Early and dynamic.Eur J Neurosci2019https://conductscience.org/library/papers/30474172PubMed
1427934604Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).Stem Cell Res2016https://conductscience.org/library/papers/27934604PubMed
1525188235Striatal astrocytes act as a reservoir for L-DOPA.PLoS One2014https://conductscience.org/library/papers/25188235PubMed
1626735016High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.Nature2016https://conductscience.org/library/papers/26735016PubMed
1729227284Cografting astrocytes improves cell therapeutic outcomes in a Parkinson's disease model.J Clin Invest2018https://conductscience.org/library/papers/29227284PubMed
1822033507Postmortem studies in Parkinson's disease.Dialogues Clin Neurosci2004https://conductscience.org/library/papers/22033507PubMed
1925494202Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex.Nature2015https://conductscience.org/library/papers/25494202PubMed
208721156Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.Exp Brain Res1996https://conductscience.org/library/papers/8721156PubMed

See all 72 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42862306CRISPR/Cas9-based nanodelivery systems for precision gene editing in neuroinflammation.Inflamm Res2026https://conductscience.org/library/papers/42862306PubMed
42563249Injectable Supramolecular Hydrogel Encapsulating CRISPR-Engineered MSCs Drives Synergistic Neuroprotection and Functional Recovery After Traumatic Brain Injury.Adv Healthc Mater2026https://conductscience.org/library/papers/42563249PubMed
42268478CRISPR-Based Gene Therapy for Brain Disease.Mol Neurobiol2026https://conductscience.org/library/papers/42268478PubMed
41877893CRISPR-based Transcriptional Regulation: Technologies, Applications, and Future Directions.DNA (Basel)2025https://conductscience.org/library/papers/41877893PubMed
41674784CRISPR-Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges.Front Neurol2025https://conductscience.org/library/papers/41674784PubMed
40759894Histone lactylation regulates DOCK4 to control heat nociception and supports Dynein-mediated Nav1.7 trafficking.Nat Commun2025https://conductscience.org/library/papers/40759894PubMed
40406119Astrocyte-mediated inflammatory responses in traumatic brain injury: mechanisms and potential interventions.Front Immunol2025https://conductscience.org/library/papers/40406119PubMed
40362507From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine.Int J Mol Sci2025https://conductscience.org/library/papers/40362507PubMed
39949490CRISPR-dCas9 Activation of TSG-6 in MSCs Modulates the Cargo of MSC-Derived Extracellular Vesicles and Attenuates Inflammatory Responses in Human Intervertebral Disc Cells In Vitro.Cell Mol Bioeng2025https://conductscience.org/library/papers/39949490PubMed
39726634Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine.Front Genome Ed2024https://conductscience.org/library/papers/39726634PubMed
39684197Advances and Challenges in Gene Therapy for Neurodegenerative Diseases: A Systematic Review.Int J Mol Sci2024https://conductscience.org/library/papers/39684197PubMed
39596436Gene Therapy for Parkinson's Disease Using Midbrain Developmental Genes to Regulate Dopaminergic Neuronal Maintenance.Int J Mol Sci2024https://conductscience.org/library/papers/39596436PubMed
39175618Assessment of CRISPRa-mediated gdnf overexpression in an In vitro Parkinson's disease model.Front Bioeng Biotechnol2024https://conductscience.org/library/papers/39175618PubMed
38180686Understanding current experimental models of glioblastoma-brain microenvironment interactions.J Neurooncol2024https://conductscience.org/library/papers/38180686PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DDC1644PubTator's text mininghttps://conductscience.org/library/genes/1644NCBI Gene
LAT27040PubTator's text mininghttps://conductscience.org/library/genes/27040NCBI Gene
SLC38A755238PubTator's text mininghttps://conductscience.org/library/genes/55238NCBI Gene
SLC6A36531PubTator's text mininghttps://conductscience.org/library/genes/6531NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37542151

GET https://conductscience.org/api/papers/v1/37542151/references?page=2